| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 108 | 2025 | 547 | 18.300 |
Why?
|
| Veterans | 66 | 2025 | 203 | 12.440 |
Why?
|
| Biomphalaria | 13 | 2025 | 18 | 6.350 |
Why?
|
| DNA Methylation | 25 | 2025 | 393 | 4.350 |
Why?
|
| Ganglia, Invertebrate | 16 | 2024 | 25 | 3.020 |
Why?
|
| Epigenesis, Genetic | 17 | 2025 | 274 | 2.500 |
Why?
|
| Schistosomiasis | 4 | 2025 | 18 | 2.350 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2025 | 727 | 2.270 |
Why?
|
| Neuropeptides | 7 | 2025 | 63 | 2.250 |
Why?
|
| Schistosomiasis mansoni | 4 | 2023 | 10 | 2.250 |
Why?
|
| Genome-Wide Association Study | 17 | 2025 | 421 | 2.210 |
Why?
|
| Host-Parasite Interactions | 5 | 2023 | 75 | 2.110 |
Why?
|
| Middle Aged | 77 | 2025 | 11819 | 1.970 |
Why?
|
| Aplysia | 12 | 2025 | 20 | 1.960 |
Why?
|
| Schistosoma mansoni | 7 | 2023 | 21 | 1.950 |
Why?
|
| Male | 99 | 2025 | 22779 | 1.910 |
Why?
|
| Adult | 78 | 2025 | 13458 | 1.910 |
Why?
|
| Spouses | 6 | 2015 | 38 | 1.890 |
Why?
|
| Prefrontal Cortex | 8 | 2024 | 160 | 1.890 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2019 | 81 | 1.830 |
Why?
|
| Severity of Illness Index | 24 | 2025 | 708 | 1.780 |
Why?
|
| Mental Disorders | 8 | 2022 | 377 | 1.690 |
Why?
|
| Humans | 128 | 2025 | 42163 | 1.680 |
Why?
|
| Psychopathology | 5 | 2023 | 20 | 1.590 |
Why?
|
| Female | 86 | 2025 | 24018 | 1.580 |
Why?
|
| Dissociative Disorders | 7 | 2023 | 18 | 1.490 |
Why?
|
| Serotonin | 3 | 2024 | 125 | 1.470 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 14 | 2022 | 116 | 1.450 |
Why?
|
| Personality Disorders | 9 | 2015 | 21 | 1.440 |
Why?
|
| Glucuronidase | 3 | 2020 | 21 | 1.430 |
Why?
|
| Brachyura | 5 | 2011 | 14 | 1.420 |
Why?
|
| Neurons | 16 | 2025 | 1246 | 1.410 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2025 | 860 | 1.350 |
Why?
|
| Combat Disorders | 8 | 2016 | 12 | 1.340 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 303 | 1.330 |
Why?
|
| Dopamine | 7 | 2020 | 272 | 1.300 |
Why?
|
| Gastropoda | 2 | 2020 | 16 | 1.250 |
Why?
|
| Young Adult | 31 | 2023 | 4936 | 1.190 |
Why?
|
| Life Change Events | 11 | 2018 | 107 | 1.190 |
Why?
|
| FMRFamide | 3 | 2023 | 12 | 1.190 |
Why?
|
| Tyrosine 3-Monooxygenase | 6 | 2018 | 88 | 1.190 |
Why?
|
| Dementia | 4 | 2024 | 155 | 1.190 |
Why?
|
| Nerve Net | 4 | 2018 | 96 | 1.170 |
Why?
|
| Central Nervous System | 7 | 2025 | 150 | 1.140 |
Why?
|
| Inflammation | 8 | 2025 | 729 | 1.110 |
Why?
|
| Anxiety Disorders | 7 | 2023 | 319 | 1.090 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 972 | 1.030 |
Why?
|
| Substance-Related Disorders | 7 | 2023 | 825 | 1.000 |
Why?
|
| Military Personnel | 9 | 2024 | 109 | 0.990 |
Why?
|
| Fear | 7 | 2023 | 271 | 0.970 |
Why?
|
| Animals | 37 | 2025 | 16695 | 0.970 |
Why?
|
| Brain | 12 | 2024 | 1452 | 0.960 |
Why?
|
| Aged | 37 | 2024 | 7982 | 0.940 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2025 | 74 | 0.940 |
Why?
|
| Comorbidity | 16 | 2025 | 725 | 0.930 |
Why?
|
| Psychiatric Status Rating Scales | 12 | 2018 | 280 | 0.920 |
Why?
|
| Expressed Emotion | 3 | 2014 | 9 | 0.920 |
Why?
|
| Cholecystokinin | 1 | 2025 | 16 | 0.910 |
Why?
|
| Spouse Abuse | 3 | 2014 | 51 | 0.900 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 577 | 0.900 |
Why?
|
| Feeding Behavior | 6 | 2018 | 461 | 0.890 |
Why?
|
| MMPI | 6 | 2023 | 11 | 0.880 |
Why?
|
| Aging | 8 | 2025 | 764 | 0.860 |
Why?
|
| Motor Neurons | 6 | 2019 | 88 | 0.860 |
Why?
|
| Amygdala | 6 | 2024 | 125 | 0.820 |
Why?
|
| Trematoda | 1 | 2023 | 3 | 0.820 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 72 | 0.810 |
Why?
|
| Genotype | 9 | 2022 | 796 | 0.810 |
Why?
|
| Waste Disposal, Fluid | 3 | 2019 | 19 | 0.800 |
Why?
|
| Stress, Psychological | 4 | 2019 | 641 | 0.780 |
Why?
|
| Sexual Partners | 3 | 2015 | 325 | 0.760 |
Why?
|
| Aggression | 6 | 2017 | 101 | 0.720 |
Why?
|
| Longitudinal Studies | 12 | 2025 | 1020 | 0.700 |
Why?
|
| Longevity | 2 | 2020 | 171 | 0.690 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2021 | 39 | 0.690 |
Why?
|
| Gyrus Cinguli | 3 | 2023 | 30 | 0.680 |
Why?
|
| Oxidative Stress | 2 | 2018 | 990 | 0.670 |
Why?
|
| Feedback, Physiological | 2 | 2011 | 32 | 0.670 |
Why?
|
| Hippocampus | 4 | 2023 | 591 | 0.670 |
Why?
|
| Aging, Premature | 1 | 2020 | 6 | 0.660 |
Why?
|
| Catecholamines | 4 | 2014 | 45 | 0.650 |
Why?
|
| Interneurons | 7 | 2018 | 64 | 0.640 |
Why?
|
| Depressive Disorder, Major | 5 | 2024 | 128 | 0.630 |
Why?
|
| Interpersonal Relations | 5 | 2015 | 216 | 0.630 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 47 | 0.610 |
Why?
|
| Nitrogen | 2 | 2017 | 83 | 0.610 |
Why?
|
| Metabolic Diseases | 2 | 2017 | 38 | 0.600 |
Why?
|
| United States | 17 | 2024 | 5072 | 0.570 |
Why?
|
| Personality | 6 | 2019 | 55 | 0.570 |
Why?
|
| Muscles | 1 | 2018 | 84 | 0.560 |
Why?
|
| Heart Rate | 3 | 2011 | 261 | 0.560 |
Why?
|
| Affect | 5 | 2014 | 177 | 0.560 |
Why?
|
| Executive Function | 1 | 2018 | 55 | 0.560 |
Why?
|
| Pharmacogenetics | 1 | 2018 | 63 | 0.550 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 61 | 0.550 |
Why?
|
| Depersonalization | 3 | 2019 | 3 | 0.550 |
Why?
|
| Oxygen | 3 | 2019 | 217 | 0.550 |
Why?
|
| C-Reactive Protein | 4 | 2025 | 164 | 0.550 |
Why?
|
| Nervous System | 2 | 2020 | 33 | 0.550 |
Why?
|
| Depressive Disorder | 3 | 2014 | 185 | 0.540 |
Why?
|
| Polymorphism, Genetic | 2 | 2022 | 200 | 0.530 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2017 | 18 | 0.530 |
Why?
|
| Self-Injurious Behavior | 1 | 2017 | 25 | 0.520 |
Why?
|
| Alcoholism | 4 | 2021 | 292 | 0.520 |
Why?
|
| Carbon | 2 | 2017 | 127 | 0.510 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 300 | 0.510 |
Why?
|
| Cognition | 1 | 2020 | 458 | 0.500 |
Why?
|
| Mortality | 1 | 2018 | 174 | 0.490 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2015 | 3 | 0.480 |
Why?
|
| Corpus Callosum | 1 | 2015 | 14 | 0.480 |
Why?
|
| Models, Psychological | 8 | 2018 | 141 | 0.480 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 61 | 0.480 |
Why?
|
| Immunohistochemistry | 6 | 2019 | 928 | 0.470 |
Why?
|
| Synaptic Transmission | 6 | 2014 | 156 | 0.470 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 27 | 0.470 |
Why?
|
| Apolipoprotein E4 | 3 | 2024 | 62 | 0.460 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 56 | 0.460 |
Why?
|
| Adaptation, Psychological | 2 | 2011 | 410 | 0.460 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 34 | 0.460 |
Why?
|
| Cheek | 3 | 2007 | 13 | 0.460 |
Why?
|
| Models, Statistical | 4 | 2014 | 190 | 0.450 |
Why?
|
| Anger | 2 | 2014 | 27 | 0.450 |
Why?
|
| Chronic Disease | 1 | 2018 | 541 | 0.440 |
Why?
|
| Statistics as Topic | 2 | 2013 | 123 | 0.440 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2014 | 16 | 0.440 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2014 | 3 | 0.440 |
Why?
|
| Bulimia Nervosa | 1 | 2014 | 5 | 0.440 |
Why?
|
| Binge-Eating Disorder | 1 | 2014 | 8 | 0.430 |
Why?
|
| Heart | 4 | 2011 | 181 | 0.430 |
Why?
|
| Suicide | 1 | 2016 | 139 | 0.430 |
Why?
|
| Neural Pathways | 4 | 2009 | 139 | 0.420 |
Why?
|
| Myocardial Contraction | 2 | 2011 | 46 | 0.420 |
Why?
|
| Mood Disorders | 1 | 2014 | 54 | 0.420 |
Why?
|
| Terrorism | 1 | 2013 | 13 | 0.420 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2013 | 2 | 0.420 |
Why?
|
| CpG Islands | 5 | 2025 | 107 | 0.420 |
Why?
|
| Afghan Campaign 2001- | 5 | 2021 | 14 | 0.420 |
Why?
|
| Potassium Channels | 1 | 2014 | 81 | 0.420 |
Why?
|
| Regression Analysis | 4 | 2018 | 487 | 0.420 |
Why?
|
| Ankyrins | 1 | 2013 | 7 | 0.410 |
Why?
|
| Psychometrics | 3 | 2019 | 350 | 0.410 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2013 | 26 | 0.410 |
Why?
|
| Hydrocortisone | 3 | 2013 | 89 | 0.410 |
Why?
|
| Genetic Variation | 1 | 2016 | 429 | 0.400 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 1058 | 0.400 |
Why?
|
| Family Conflict | 1 | 2013 | 13 | 0.400 |
Why?
|
| Vietnam Conflict | 3 | 2010 | 6 | 0.390 |
Why?
|
| Survivors | 3 | 2023 | 152 | 0.380 |
Why?
|
| Genetic Loci | 2 | 2024 | 102 | 0.360 |
Why?
|
| Personality Tests | 1 | 2011 | 7 | 0.360 |
Why?
|
| Rape | 2 | 2013 | 16 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 382 | 0.360 |
Why?
|
| Action Potentials | 6 | 2011 | 246 | 0.350 |
Why?
|
| Blast Injuries | 2 | 2021 | 6 | 0.350 |
Why?
|
| Neurotransmitter Agents | 3 | 2020 | 69 | 0.350 |
Why?
|
| Extremities | 2 | 2018 | 20 | 0.340 |
Why?
|
| Resilience, Psychological | 3 | 2017 | 89 | 0.340 |
Why?
|
| Periodicity | 2 | 2009 | 34 | 0.330 |
Why?
|
| Synapses | 3 | 2006 | 184 | 0.320 |
Why?
|
| Cohort Studies | 9 | 2025 | 1729 | 0.320 |
Why?
|
| Bioreactors | 4 | 2019 | 29 | 0.320 |
Why?
|
| Dendrites | 1 | 2009 | 57 | 0.310 |
Why?
|
| Depression | 9 | 2023 | 837 | 0.310 |
Why?
|
| Personality Inventory | 5 | 2015 | 82 | 0.310 |
Why?
|
| Repressor Proteins | 3 | 2020 | 267 | 0.310 |
Why?
|
| Models, Theoretical | 1 | 2010 | 230 | 0.300 |
Why?
|
| Sex Factors | 5 | 2019 | 1008 | 0.300 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 1188 | 0.300 |
Why?
|
| Obesity | 1 | 2017 | 1131 | 0.300 |
Why?
|
| Temperament | 3 | 2018 | 36 | 0.300 |
Why?
|
| Diseases in Twins | 3 | 2017 | 7 | 0.290 |
Why?
|
| Electric Stimulation | 4 | 2011 | 198 | 0.290 |
Why?
|
| Emotions | 4 | 2022 | 251 | 0.290 |
Why?
|
| Peripheral Nervous System | 3 | 2018 | 14 | 0.290 |
Why?
|
| Risk Factors | 8 | 2024 | 3942 | 0.290 |
Why?
|
| Case-Control Studies | 5 | 2020 | 1266 | 0.280 |
Why?
|
| Malingering | 2 | 2023 | 3 | 0.280 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3077 | 0.280 |
Why?
|
| Aged, 80 and over | 7 | 2024 | 2803 | 0.280 |
Why?
|
| Membrane Transport Modulators | 1 | 2007 | 4 | 0.280 |
Why?
|
| Alleles | 3 | 2020 | 352 | 0.280 |
Why?
|
| Factor Analysis, Statistical | 4 | 2015 | 157 | 0.270 |
Why?
|
| Species Specificity | 4 | 2018 | 279 | 0.270 |
Why?
|
| Multifactorial Inheritance | 2 | 2017 | 32 | 0.270 |
Why?
|
| Movement | 1 | 2007 | 116 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 89 | 0.250 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 38 | 0.250 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2006 | 55 | 0.240 |
Why?
|
| Internal-External Control | 3 | 2016 | 60 | 0.230 |
Why?
|
| Sulpiride | 3 | 2014 | 6 | 0.230 |
Why?
|
| Ammonia | 2 | 2015 | 22 | 0.230 |
Why?
|
| Neuronal Plasticity | 1 | 2006 | 126 | 0.230 |
Why?
|
| Nitrites | 2 | 2015 | 54 | 0.230 |
Why?
|
| Lymnaea | 2 | 2018 | 3 | 0.230 |
Why?
|
| Arousal | 6 | 2014 | 95 | 0.220 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 10 | 0.220 |
Why?
|
| Personal Satisfaction | 2 | 2015 | 74 | 0.220 |
Why?
|
| Nitrates | 2 | 2015 | 63 | 0.220 |
Why?
|
| Boston | 2 | 2014 | 31 | 0.220 |
Why?
|
| Prevalence | 8 | 2020 | 1597 | 0.220 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 118 | 0.210 |
Why?
|
| Perfusion | 2 | 2020 | 39 | 0.210 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 234 | 0.210 |
Why?
|
| Pain Clinics | 1 | 2023 | 4 | 0.210 |
Why?
|
| Phenotype | 4 | 2023 | 774 | 0.210 |
Why?
|
| Dopamine Antagonists | 3 | 2018 | 48 | 0.210 |
Why?
|
| Antisocial Personality Disorder | 2 | 2014 | 20 | 0.210 |
Why?
|
| Internal Capsule | 1 | 2023 | 3 | 0.200 |
Why?
|
| Wrist | 1 | 2023 | 7 | 0.200 |
Why?
|
| Anxiety | 5 | 2023 | 847 | 0.200 |
Why?
|
| Biotin | 1 | 2003 | 24 | 0.200 |
Why?
|
| Appetite | 1 | 2003 | 21 | 0.200 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 25 | 0.200 |
Why?
|
| Dreams | 1 | 2022 | 10 | 0.190 |
Why?
|
| Imagination | 1 | 2002 | 9 | 0.190 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 599 | 0.190 |
Why?
|
| Electrophysiology | 3 | 2009 | 138 | 0.190 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 281 | 0.190 |
Why?
|
| Carrier Proteins | 1 | 2024 | 318 | 0.180 |
Why?
|
| Child Abuse | 1 | 2023 | 90 | 0.180 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 31 | 0.180 |
Why?
|
| Bayes Theorem | 1 | 2022 | 121 | 0.180 |
Why?
|
| Genomics | 3 | 2022 | 289 | 0.180 |
Why?
|
| Genome | 1 | 2022 | 149 | 0.180 |
Why?
|
| Impulsive Behavior | 2 | 2018 | 54 | 0.180 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.180 |
Why?
|
| Frontal Lobe | 2 | 2020 | 58 | 0.170 |
Why?
|
| Mollusca | 1 | 2020 | 16 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 245 | 0.170 |
Why?
|
| Adolescent | 8 | 2016 | 5950 | 0.170 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 14 | 0.170 |
Why?
|
| Corpus Striatum | 2 | 2018 | 119 | 0.160 |
Why?
|
| Sulfotransferases | 1 | 2020 | 9 | 0.160 |
Why?
|
| Gonads | 1 | 2020 | 21 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 88 | 0.160 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 5 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 114 | 0.160 |
Why?
|
| Organ Size | 2 | 2017 | 167 | 0.160 |
Why?
|
| Atrophy | 1 | 2019 | 51 | 0.150 |
Why?
|
| Sewage | 1 | 2019 | 27 | 0.150 |
Why?
|
| Pilot Projects | 3 | 2017 | 733 | 0.150 |
Why?
|
| Pleurobranchaea | 1 | 2018 | 1 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2024 | 845 | 0.150 |
Why?
|
| Interleukin-1alpha | 1 | 2018 | 18 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 170 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 90 | 0.150 |
Why?
|
| Sensory Receptor Cells | 1 | 2018 | 34 | 0.150 |
Why?
|
| Membrane Potentials | 2 | 2011 | 221 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 557 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 448 | 0.140 |
Why?
|
| Blinking | 2 | 2011 | 14 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 37 | 0.140 |
Why?
|
| Muscle Contraction | 2 | 2009 | 67 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 239 | 0.140 |
Why?
|
| Motor Vehicles | 3 | 2022 | 15 | 0.140 |
Why?
|
| Wounds and Injuries | 2 | 2020 | 191 | 0.140 |
Why?
|
| Suicide, Attempted | 2 | 2016 | 104 | 0.130 |
Why?
|
| Accidents, Traffic | 3 | 2022 | 46 | 0.130 |
Why?
|
| Registries | 2 | 2017 | 431 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 101 | 0.130 |
Why?
|
| Gambling | 1 | 2017 | 21 | 0.130 |
Why?
|
| Mechanoreceptors | 2 | 2009 | 17 | 0.130 |
Why?
|
| Triazines | 1 | 2017 | 25 | 0.130 |
Why?
|
| Pattern Recognition, Automated | 1 | 2017 | 32 | 0.130 |
Why?
|
| Analysis of Variance | 2 | 2009 | 574 | 0.130 |
Why?
|
| Phylogeny | 1 | 2020 | 740 | 0.130 |
Why?
|
| Reproduction | 2 | 2019 | 92 | 0.130 |
Why?
|
| Cues | 2 | 2009 | 75 | 0.130 |
Why?
|
| Sleep | 2 | 2023 | 179 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1066 | 0.120 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2006 | 80 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 28 | 0.120 |
Why?
|
| Implosive Therapy | 1 | 2016 | 14 | 0.120 |
Why?
|
| Myocardium | 2 | 2009 | 251 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 137 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 311 | 0.120 |
Why?
|
| Psychotherapy, Group | 1 | 2016 | 23 | 0.120 |
Why?
|
| Bacteria, Anaerobic | 1 | 2015 | 11 | 0.120 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2015 | 89 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2017 | 253 | 0.120 |
Why?
|
| Histamine | 1 | 2015 | 20 | 0.120 |
Why?
|
| Water Purification | 1 | 2015 | 33 | 0.120 |
Why?
|
| Psychological Tests | 1 | 2015 | 56 | 0.110 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2014 | 12 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 2 | 2007 | 228 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2020 | 452 | 0.110 |
Why?
|
| Glutaral | 1 | 2014 | 4 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 602 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 661 | 0.110 |
Why?
|
| Formaldehyde | 1 | 2014 | 30 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2014 | 56 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1112 | 0.110 |
Why?
|
| Bombs | 1 | 2013 | 1 | 0.110 |
Why?
|
| Explosions | 1 | 2013 | 6 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1586 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 170 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2004 | 206 | 0.100 |
Why?
|
| Hostility | 1 | 2013 | 7 | 0.100 |
Why?
|
| Electromyography | 2 | 2004 | 69 | 0.100 |
Why?
|
| Couples Therapy | 1 | 2013 | 3 | 0.100 |
Why?
|
| Child Abuse, Sexual | 1 | 2013 | 22 | 0.100 |
Why?
|
| Marriage | 1 | 2013 | 18 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 236 | 0.090 |
Why?
|
| Lead | 1 | 2013 | 101 | 0.090 |
Why?
|
| Borderline Personality Disorder | 1 | 2012 | 36 | 0.090 |
Why?
|
| Ligation | 1 | 2011 | 12 | 0.090 |
Why?
|
| Tetrodotoxin | 1 | 2011 | 23 | 0.090 |
Why?
|
| Sucrose | 1 | 2011 | 33 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 143 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2011 | 81 | 0.090 |
Why?
|
| Placebos | 1 | 2011 | 41 | 0.090 |
Why?
|
| Mental Status Schedule | 1 | 2010 | 18 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2013 | 247 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2011 | 305 | 0.080 |
Why?
|
| Reflex, Stretch | 1 | 2009 | 1 | 0.080 |
Why?
|
| Neurophysiology | 1 | 2009 | 10 | 0.080 |
Why?
|
| Portraits as Topic | 1 | 2009 | 2 | 0.080 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 4 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 1051 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2009 | 22 | 0.080 |
Why?
|
| Pharynx | 1 | 2009 | 16 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 683 | 0.080 |
Why?
|
| Health Surveys | 3 | 2016 | 401 | 0.080 |
Why?
|
| Esophagus | 1 | 2009 | 44 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 67 | 0.070 |
Why?
|
| Photic Stimulation | 1 | 2009 | 123 | 0.070 |
Why?
|
| Eating | 1 | 2009 | 164 | 0.070 |
Why?
|
| Veterans Disability Claims | 1 | 2008 | 1 | 0.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 297 | 0.070 |
Why?
|
| Agoraphobia | 1 | 2008 | 17 | 0.070 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2008 | 25 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2008 | 74 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2013 | 634 | 0.070 |
Why?
|
| Cesium | 1 | 2007 | 8 | 0.070 |
Why?
|
| Cholinergic Agonists | 1 | 2007 | 7 | 0.070 |
Why?
|
| Carbachol | 1 | 2007 | 19 | 0.070 |
Why?
|
| Drug Administration Routes | 1 | 2007 | 14 | 0.070 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2007 | 12 | 0.070 |
Why?
|
| Conduct Disorder | 1 | 2007 | 54 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2023 | 638 | 0.060 |
Why?
|
| Reaction Time | 1 | 2007 | 151 | 0.060 |
Why?
|
| Galvanic Skin Response | 1 | 2006 | 16 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2006 | 55 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2008 | 134 | 0.060 |
Why?
|
| Dopamine Agents | 1 | 2006 | 28 | 0.060 |
Why?
|
| Health Policy | 1 | 2008 | 184 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2006 | 60 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2006 | 135 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 156 | 0.060 |
Why?
|
| Baclofen | 1 | 2004 | 9 | 0.060 |
Why?
|
| Child | 1 | 2013 | 3381 | 0.060 |
Why?
|
| Peptides | 1 | 2007 | 357 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2025 | 99 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2007 | 369 | 0.050 |
Why?
|
| Systems Biology | 1 | 2024 | 26 | 0.050 |
Why?
|
| Pheromones | 1 | 2004 | 18 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 1 | 2004 | 33 | 0.050 |
Why?
|
| Neutrophils | 1 | 2025 | 141 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2025 | 183 | 0.050 |
Why?
|
| Mental Recall | 1 | 2004 | 81 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2024 | 198 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2485 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 471 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2004 | 127 | 0.050 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2004 | 59 | 0.050 |
Why?
|
| Anisotropy | 1 | 2023 | 33 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 30 | 0.050 |
Why?
|
| Peripheral Nerves | 1 | 2003 | 14 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2023 | 92 | 0.050 |
Why?
|
| Attention | 1 | 2004 | 165 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2022 | 103 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2002 | 38 | 0.050 |
Why?
|
| Prognosis | 1 | 2025 | 850 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2022 | 165 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 230 | 0.040 |
Why?
|
| Kynurenine | 1 | 2020 | 8 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 266 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 379 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 268 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2020 | 55 | 0.040 |
Why?
|
| Pain | 1 | 2023 | 283 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 79 | 0.040 |
Why?
|
| Brain Concussion | 1 | 2020 | 35 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1265 | 0.040 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 17 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 246 | 0.040 |
Why?
|
| Antibodies | 1 | 2019 | 140 | 0.040 |
Why?
|
| Solubility | 1 | 2019 | 134 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 310 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 86 | 0.040 |
Why?
|
| Personality Assessment | 1 | 2018 | 44 | 0.040 |
Why?
|
| Dopamine Agonists | 1 | 2018 | 34 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 1574 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 436 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2017 | 11 | 0.030 |
Why?
|
| Thalamus | 1 | 2017 | 34 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 61 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 960 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 255 | 0.030 |
Why?
|
| Smoking | 1 | 2023 | 1019 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 2015 | 17 | 0.030 |
Why?
|
| Ganglia | 1 | 2015 | 12 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 692 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2004 | 2111 | 0.030 |
Why?
|
| Rest | 1 | 2015 | 33 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1804 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 1737 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 132 | 0.030 |
Why?
|
| Temperature | 1 | 2015 | 314 | 0.030 |
Why?
|
| Death, Sudden | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 250 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2013 | 74 | 0.020 |
Why?
|
| Awareness | 1 | 2013 | 73 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 67 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2013 | 115 | 0.020 |
Why?
|
| Saliva | 1 | 2013 | 115 | 0.020 |
Why?
|
| Sex Offenses | 1 | 2012 | 43 | 0.020 |
Why?
|
| Bacteria | 1 | 2014 | 285 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 438 | 0.020 |
Why?
|
| Twins | 1 | 2010 | 18 | 0.020 |
Why?
|
| Self Concept | 1 | 2011 | 170 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 95 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2009 | 9 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 236 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2009 | 45 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 35 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 2009 | 34 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1848 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 6490 | 0.020 |
Why?
|
| Visual Perception | 1 | 2009 | 75 | 0.020 |
Why?
|
| Twin Studies as Topic | 1 | 2007 | 3 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1554 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 162 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 404 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 508 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 51 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1559 | 0.010 |
Why?
|